drugset / Trial / NCT01915147

A Study to Explore the Influence of Two Opioid Pain Medications on Bacterial Composition in the Gut and Other Gastrointestinal Aspects

NCT01915147

Phase 2 Completed 108 enrolled Mundipharma Research GmbH & Co KG
RandomizedCrossoverDouble-blindTreatment

Summary

The study is intended to explore changes in the composition and quantity of gut bacteria subject to treatment with strong pain medication. Two pain medications will be compared (OXN PR and OxyPR). Other gastrointestinal parameters will be assessed.

Timeline

Start
2013-07
Primary completion
2015-02
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject OXN PR Unknown
Subject Oxycodone Other / unclassified

Indications